ATE173405T1 - Arzneimittel auf basis von hyaluronsäure - Google Patents
Arzneimittel auf basis von hyaluronsäureInfo
- Publication number
- ATE173405T1 ATE173405T1 AT92111469T AT92111469T ATE173405T1 AT E173405 T1 ATE173405 T1 AT E173405T1 AT 92111469 T AT92111469 T AT 92111469T AT 92111469 T AT92111469 T AT 92111469T AT E173405 T1 ATE173405 T1 AT E173405T1
- Authority
- AT
- Austria
- Prior art keywords
- water
- pharmacologically active
- hyaluronic acid
- soluble
- products based
- Prior art date
Links
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title abstract 2
- 229920002674 hyaluronan Polymers 0.000 title abstract 2
- 229960003160 hyaluronic acid Drugs 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 1
- 239000013543 active substance Substances 0.000 abstract 2
- 102000003951 Erythropoietin Human genes 0.000 abstract 1
- 108090000394 Erythropoietin Proteins 0.000 abstract 1
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 239000010839 body fluid Substances 0.000 abstract 1
- 229940105423 erythropoietin Drugs 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17020591 | 1991-07-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE173405T1 true ATE173405T1 (de) | 1998-12-15 |
Family
ID=15900617
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92111469T ATE173405T1 (de) | 1991-07-10 | 1992-07-07 | Arzneimittel auf basis von hyaluronsäure |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0522491B1 (de) |
| AT (1) | ATE173405T1 (de) |
| CA (1) | CA2073554C (de) |
| DE (1) | DE69227607T2 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6074512A (en) * | 1991-06-27 | 2000-06-13 | Applied Materials, Inc. | Inductively coupled RF plasma reactor having an overhead solenoidal antenna and modular confinement magnet liners |
| SE9400036D0 (sv) * | 1994-01-10 | 1994-01-10 | Pharmacia Ab | Low modecular weight hyaluronic acid |
| IL113010A0 (en) * | 1994-03-31 | 1995-10-31 | Pharmacia Ab | Pharmaceutical formulation comprising factor VIII or factor ix with an activity of at least 200 IU/ml and an enhancer for improved subcutaneous intramuscular or intradermal administration |
| US5858477A (en) | 1996-12-10 | 1999-01-12 | Akashic Memories Corporation | Method for producing recording media having protective overcoats of highly tetrahedral amorphous carbon |
| SE9904121D0 (sv) | 1999-11-15 | 1999-11-15 | Gustaf Jederstroem | Hydrophobe biomolecular structure |
| JP2002003398A (ja) * | 2000-04-17 | 2002-01-09 | Ltt Institute Co Ltd | 徐放製剤、その製造法及びワクチン |
| DE10064219B9 (de) * | 2000-12-22 | 2009-02-12 | Nasalis Pain Relief International Gmbh | Neue Fentanyl und/oder dessen Derivate enthaltende pharmazeutische Zusammensetzung zur nasalen Anwendung |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1340994C (en) * | 1989-09-21 | 2000-05-16 | Rudolf Edgar Dr. Falk | Treatment of conditions and disease |
-
1992
- 1992-07-07 AT AT92111469T patent/ATE173405T1/de not_active IP Right Cessation
- 1992-07-07 EP EP92111469A patent/EP0522491B1/de not_active Expired - Lifetime
- 1992-07-07 DE DE69227607T patent/DE69227607T2/de not_active Expired - Fee Related
- 1992-07-09 CA CA002073554A patent/CA2073554C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69227607D1 (de) | 1998-12-24 |
| CA2073554A1 (en) | 1993-01-11 |
| EP0522491B1 (de) | 1998-11-18 |
| CA2073554C (en) | 2003-06-10 |
| DE69227607T2 (de) | 1999-04-15 |
| EP0522491A1 (de) | 1993-01-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69434963D1 (de) | Selektiv auf die leber wirkende pharmazeutisch aktive substanz | |
| ATE189772T1 (de) | Unter wärmeeinwirkung reversibel gelierende medizinische zusammensetzung auf wasserbasis | |
| DE69428040D1 (de) | Orale darreichungsform | |
| DE68901140D1 (de) | Waessrige loesung von fettloeslichen wirkstoffen. | |
| NO904378D0 (no) | Fremgangsmaate for fremstilling av et modifisert protein for terapeutisk anvendelse. | |
| DE69230112D1 (de) | Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin | |
| CY1110078T1 (el) | Παρασκευασματα με ιωδιουχο ποβιδονη για την αγωγη τραυματων | |
| ZA909762B (en) | Process for the production of biologically active protein | |
| ATA21888A (de) | Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken | |
| DE69227607D1 (de) | Arzneimittel auf Basis von Hyaluronsäure | |
| DE60018409D1 (de) | Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren | |
| GB1395090A (en) | Stabilized hormone compositions | |
| DK0559145T3 (da) | Lægemiddel til truende abort | |
| DE60028559D1 (de) | Behandlung von multiplersklerose mit einer kombination von interferon und wachstumshormone | |
| ES2182840T3 (es) | Factor xiii para el tratamiento de heridas de la piel. | |
| DE3781682D1 (de) | Verbesserungen im gebrauch oder in bezug auf den gebrauch von egf. | |
| DK15088D0 (da) | Antibakterielt lyofiliseret praeparat | |
| ATE107504T1 (de) | Arzneimittel zur behandlung von kryptosporidiose. | |
| ES2163966A1 (es) | Glicoconjugados constituidos por la asociacion no covalente de polisacaridos con polipetidos. | |
| IL110888A0 (en) | Pharmaceutical compositions for the treatment of liver diseases comprising a benzothiazepine derivative | |
| RU93052444A (ru) | Лекарственный препарат бан | |
| IT8435936U1 (it) | Siringa per uso sanitario, umano e veterinario, con innesto dell'ago al terminale del cilindro su perno (centrato e/o decentrato) perpendicolare ad esso, con stantuffo che funge da custodia dell'ago | |
| RU98109592A (ru) | Применение белка s-100b в лекарственных средствах и лекарственные средства, содержащие белок s-100b | |
| CA2159609A1 (en) | Factor xiii for treatment of skin wounds | |
| KR900701307A (ko) | 항 비루스성 또는 항 박테리아성 화합물과 그 사용방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |